IP Library Granted Patent US 7,972,870
Granted Patent B2
US 7,972,870 · App. 12/024,692 · Granted Jul 5, 2011

Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3

Assignee: Dana-Farber Cancer Institute, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,972,870
App. No.
12/024,692
Granted
Jul 5, 2011
Kind
B2
Abstract

This invention relates to regulation of cell signaling, cell growth, and more particularly to the regulation of cancer or inflammatory cell growth and/or activation. The invention provides methods of inhibiting interactions between MUC1 and a heat shock factor, method of inhibiting interactions between transcription factors and the MUC1 promoter, and methods of inhibiting MUC1 expression. The invention also provides screening methods for identifying compounds that inhibit the aforementioned interactions. Pharmaceutical compositions containing the identified compounds can be useful in treating cancers and inflammatory conditions.

Claims (3)

1. A method of identifying a compound that inhibits the binding of MUC1 to STAT3, the method comprising:

(a) contacting a MUC1 reagent comprising SEQ ID NO:2 with a STAT3 reagent comprising SEQ ID NO:5 in the presence of a candidate compound; and

(b) determining whether the candidate compound inhibits binding of the MUC1 reagent to the STAT3 reagent.

Assignments (3)
CONFIRMATORY LICENSE Recorded Sep 26, 2016
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 039851/0544 →
CONFIRMATORY LICENSE Recorded Aug 8, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039601/0380 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2008
From: KUFE, DONALD W.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 021421/0228 →
Continuity (2)
Provisional Application 60888014 · Feb 2, 2007
Related Publication 20090092600A1 · Apr 9, 2009